Integrated Research (IRI) Trading Update summary
Event summary combining transcript, slides, and related documents.
Trading Update summary
13 Jun, 2025Financial performance highlights
Total Contract Value (TCV) rebounded to $82–84m, up 20%–23% year-on-year, with statutory revenue also rising 17%–20% to $82–84m.
Statutory EBITDA expected at $23–25m, a 90%–107% increase, driven by higher revenue and 18%–19% lower operating costs.
Cash at bank rose 72% to $31.9m, reflecting improved collections and financial performance.
Pro-forma revenue slightly declined by 1%–2% to $74–75m, due to revenue recognition changes.
Business drivers and segment performance
High renewals, especially in Transact and Infrastructure, and new Collaborate wins in the Americas supported growth.
Americas revenue grew 35%–40%, while Asia-Pacific declined 5%–10% and Europe contracted 25%–30%.
Collaborate segment faced ongoing churn, impacting overall performance in some regions.
Strategic outlook and guidance
FY2025 renewals expected to be second-half weighted, with greater reliance on new business for full-year results.
Current financial strength enables a review of resourcing and capital plans to support product-led growth.
Focus remains on developing new products to drive incremental revenue and address gaps in commercialization.
Latest events from Integrated Research
- AI-driven innovation and hybrid pricing fuel growth and expand market reach.IRI
Investor Day 202624 Mar 2026 - Revenue and profit down, but strong cash and new AI products support product-led growth.IRI
H1 202626 Feb 2026 - Product-led growth and AI innovation drive future focus amid short-term profit decline.IRI
AGM 20253 Feb 2026 - Statutory revenue up 19%, net cash up 72%, with FY25 focused on product-led growth.IRI
H2 202423 Jan 2026 - Revenue and profit surged, board refreshed, and product-led cloud strategy drives future growth.IRI
AGM 202412 Jan 2026 - New business revenue surged 76% year-over-year, offsetting weaker renewals and profit declines.IRI
H1 20253 Dec 2025 - Profits fell as investment in product-led growth and AI accelerates, targeting future growth.IRI
H2 202524 Nov 2025 - New business TCV surges 87% as IR pivots to product-led growth despite overall revenue decline.IRI
Trading Update13 Jun 2025 - New business TCV jumps 77% as EBITDA beats guidance and cash remains stable.IRI
Trading Update6 Jun 2025